Imbalanced mitochondrial dynamics in human and mouse PD brains

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Mitochondrial dysfunction is central to Parkinson's disease (PD) pathogenesis.
• Dysregulation of mitochondrial dynamics, including fission and fusion, negatively impacts mitochondrial health.
• Dynamin-related protein 1 (Drp1) controls mitochondrial fission, and its inhibition shows promise in PD models.

Purpose of the Study:

• To investigate the expression of Drp1 and other mitochondrial dynamics proteins in human PD brains.
• To examine Drp1 expression and activity in a mouse model of PD.
• To determine if targeting Drp1 is a viable therapeutic strategy for PD.

Main Methods:

• Post-mortem substantia nigra specimens from PD patients and controls were analyzed.
• Immunostaining was used to assess Drp1 expression in different cell types.
• Transgenic mice overexpressing alpha-synuclein (SNCA) were used for time-course studies.

Main Results:

• Significant increases in DNM1L (encoding Drp1) and Drp1 protein levels were observed in PD brains.
• Drp1 expression was elevated in dopamine neurons, astrocytes, and microglia of PD patients.
• Mice overexpressing SNCA showed increased Drp1 upregulation and phosphorylation, indicating enhanced mitochondrial fragmentation.

Conclusions:

• The study demonstrates Drp1 upregulation and a pro-fission phenotype in both human and mouse PD brains.
• Altered expression of other fission/fusion proteins further supports mitochondrial dynamics dysregulation in PD.
• Targeting mitochondrial fission or promoting fusion presents a potential therapeutic avenue for Parkinson's disease.